Nocturia - 2018 Pipeline Insights - ResearchAndMarkets.com

DUBLIN--()--The "Nocturia - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Nocturia development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type

Scope

  • The report provides a snapshot of the pipeline development for Nocturia
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Nocturia
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Nocturia
  • The report also covers the dormant and discontinued pipeline projects related to Nocturia

Companies Featured

  • Allergan PLC
  • Astellas Pharma Inc.
  • Ferring International Center S.A.
  • Sanwa Kagaku Kenkyusho Co. Ltd.
  • Vantia Therapeutics

Key Topics Covered

1. Report Introduction

2. Nocturia Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Nocturia

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/mdw7rc/nocturia_2018?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Urological Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Urological Disorders Drugs